S&P 500   4,238.06 (-1.07%)
DOW   33,751.40 (-0.73%)
QQQ   324.66 (-1.40%)
AAPL   173.08 (-0.61%)
MSFT   287.33 (-0.98%)
META   170.27 (-2.51%)
GOOGL   118.03 (-1.78%)
AMZN   139.54 (-1.94%)
TSLA   889.12 (-2.15%)
NVDA   182.16 (-2.97%)
NIO   19.31 (-3.01%)
BABA   90.03 (-0.78%)
AMD   97.71 (-2.72%)
T   18.47 (+0.22%)
MU   61.16 (-2.89%)
CGC   3.74 (-1.84%)
F   15.95 (-1.24%)
GE   77.92 (-1.63%)
DIS   119.90 (-2.26%)
AMC   18.36 (-4.82%)
PYPL   96.83 (-3.03%)
PFE   49.09 (+1.05%)
NFLX   238.86 (-2.57%)
S&P 500   4,238.06 (-1.07%)
DOW   33,751.40 (-0.73%)
QQQ   324.66 (-1.40%)
AAPL   173.08 (-0.61%)
MSFT   287.33 (-0.98%)
META   170.27 (-2.51%)
GOOGL   118.03 (-1.78%)
AMZN   139.54 (-1.94%)
TSLA   889.12 (-2.15%)
NVDA   182.16 (-2.97%)
NIO   19.31 (-3.01%)
BABA   90.03 (-0.78%)
AMD   97.71 (-2.72%)
T   18.47 (+0.22%)
MU   61.16 (-2.89%)
CGC   3.74 (-1.84%)
F   15.95 (-1.24%)
GE   77.92 (-1.63%)
DIS   119.90 (-2.26%)
AMC   18.36 (-4.82%)
PYPL   96.83 (-3.03%)
PFE   49.09 (+1.05%)
NFLX   238.86 (-2.57%)
S&P 500   4,238.06 (-1.07%)
DOW   33,751.40 (-0.73%)
QQQ   324.66 (-1.40%)
AAPL   173.08 (-0.61%)
MSFT   287.33 (-0.98%)
META   170.27 (-2.51%)
GOOGL   118.03 (-1.78%)
AMZN   139.54 (-1.94%)
TSLA   889.12 (-2.15%)
NVDA   182.16 (-2.97%)
NIO   19.31 (-3.01%)
BABA   90.03 (-0.78%)
AMD   97.71 (-2.72%)
T   18.47 (+0.22%)
MU   61.16 (-2.89%)
CGC   3.74 (-1.84%)
F   15.95 (-1.24%)
GE   77.92 (-1.63%)
DIS   119.90 (-2.26%)
AMC   18.36 (-4.82%)
PYPL   96.83 (-3.03%)
PFE   49.09 (+1.05%)
NFLX   238.86 (-2.57%)
S&P 500   4,238.06 (-1.07%)
DOW   33,751.40 (-0.73%)
QQQ   324.66 (-1.40%)
AAPL   173.08 (-0.61%)
MSFT   287.33 (-0.98%)
META   170.27 (-2.51%)
GOOGL   118.03 (-1.78%)
AMZN   139.54 (-1.94%)
TSLA   889.12 (-2.15%)
NVDA   182.16 (-2.97%)
NIO   19.31 (-3.01%)
BABA   90.03 (-0.78%)
AMD   97.71 (-2.72%)
T   18.47 (+0.22%)
MU   61.16 (-2.89%)
CGC   3.74 (-1.84%)
F   15.95 (-1.24%)
GE   77.92 (-1.63%)
DIS   119.90 (-2.26%)
AMC   18.36 (-4.82%)
PYPL   96.83 (-3.03%)
PFE   49.09 (+1.05%)
NFLX   238.86 (-2.57%)
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

$18.24
+0.08 (+0.44%)
(As of 08/19/2022 09:34 AM ET)
Add
Compare
Today's Range
$18.16
$18.24
50-Day Range
$18.16
$26.73
52-Week Range
$18.05
$40.45
Volume
1,028 shs
Average Volume
828,770 shs
Market Capitalization
$10.69 billion
P/E Ratio
11.62
Dividend Yield
2.67%
Price Target
$45.83

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
Hold
2.18 Rating Score
Upside/​Downside
152.4% Upside
$45.83 Price Target
Short Interest
Healthy
0.17% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.25mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.38%
From $1.67 to $1.86 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.22 out of 5 stars

Medical Sector

15th out of 1,119 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

2nd out of 12 stocks

FMS stock logo

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Fresenius Medical Care AG & Co. KGaA stock traded down $0.23 during trading hours on Thursday, reaching $18.16. 736,552 shares of the stock were exchanged, compared to its average volume of 627,055. The stock has a market cap of $10.64 billion, a P/E ratio of 11.71, a P/E/G ratio of 0.93 and a beta of 1.02. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.85 and a current ratio of 1.18. Fresenius Medical Care AG & Co. KGaA has a 52-week low of $18.05 and a 52-week high of $40.45. The firm's 50 day moving average is $22.68 and its 200 day moving average is $28.80.

Analysts Set New Price Targets

Several research analysts have recently issued reports on FMS shares. StockNews.com cut shares of Fresenius Medical Care AG & Co. KGaA from a "strong-buy" rating to a "buy" rating in a report on Friday, July 15th. Truist Financial lowered their target price on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a "hold" rating for the company in a report on Wednesday, June 22nd. JPMorgan Chase & Co. reduced their price target on shares of Fresenius Medical Care AG & Co. KGaA from €51.00 ($52.04) to €23.00 ($23.47) in a research report on Monday, August 1st. Berenberg Bank reduced their price target on shares of Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a research report on Wednesday, August 10th. Finally, DZ Bank downgraded shares of Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "hold" rating in a research report on Friday, July 29th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $45.83.

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

Investors See Opportunity in Huge Global Demand for Lithium
The global lithium market is projected to surge 500% due to a growing need for lithium-filled batteries. And one junior mining company in a renowned location in South America is in the right place at the right time to capitalize on this megatrend.
Is the US Military Secretly Under Chinese Control?
Alarmingly, the answer may be "yes". Communist China now controls 80% of the lithium that powers most US military vehicles and equipment. The threat level is so high that the White House recently declared a state of emergency on lithium...
See More Headlines
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings
11/02/2021
Ex-Dividend for 5/27 Dividend
5/13/2022
Dividend Payable
5/27/2022
Today
8/19/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
122,909
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$45.83
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+151.3%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

Net Income
$1.15 billion
Pretax Margin
7.48%

Debt

Sales & Book Value

Annual Sales
$20.85 billion
Cash Flow
$5.29 per share
Book Value
$28.06 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.69 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Mr. Robert Maurice Powell Jr. (Age 67)
    Chairman of the Management Board & CEO of Fresenius Medical Care Management AG
    Comp: $3.56M
  • Ms. Helen Giza (Age 54)
    Deputy CEO, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Med. Care Mgmt AG
    Comp: $1.84M
  • Dr. Franklin W. Maddux F.A.C.P. (Age 65)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $1.64M
  • Mr. William J. Valle (Age 62)
    Management Board Member for Care Delivery of Fresenius Medical Care Management AG
    Comp: $4.05M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 59)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $4.51M
  • Mr. Roberto Fuste (Age 70)
    Exec. Advisor for Regional Strategy
  • Dr. Nwamaka Eneanya M.D.
    Head of Strategy & Operations
  • Dr. Dominik Heger
    Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller (Age 61)
    Sr. VP of Global HR Employee Communications
  • Mr. Joachim Weith
    Sr. VP of Corp. Communications & Gov.al Affairs













FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2022?

11 brokers have issued twelve-month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $23.00 to $72.00. On average, they anticipate the company's share price to reach $45.83 in the next twelve months. This suggests a possible upside of 152.4% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2022?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $32.46 at the beginning of 2022. Since then, FMS shares have decreased by 44.1% and is now trading at $18.16.
View the best growth stocks for 2022 here
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a decline in short interest in July. As of July 31st, there was short interest totaling 1,010,000 shares, a decline of 9.0% from the July 15th total of 1,110,000 shares. Based on an average daily trading volume, of 790,600 shares, the days-to-cover ratio is presently 1.3 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our FMS earnings forecast
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its quarterly earnings data on Tuesday, November, 2nd. The company reported $0.55 earnings per share for the quarter, meeting the consensus estimate of $0.55. The company earned $5.24 billion during the quarter, compared to analyst estimates of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.42% and a trailing twelve-month return on equity of 6.70%.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Stockholders of record on Monday, May 16th will be given a dividend of $0.7093 per share on Friday, May 27th. This represents a dividend yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
Read our dividend analysis for FMS
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.67%. The dividend payout ratio is 31.21%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 26.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by many different retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (2.25%), Cambiar Investors LLC (0.18%), Tweedy Browne Co LLC (0.17%), Millennium Management LLC (0.11%), Envestnet Asset Management Inc. (0.04%) and Clearbridge Investments LLC (0.04%).

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $18.16.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $10.64 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.57 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 122,909 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
When was Fresenius Medical Care AG & Co. KGaA founded?

Fresenius Medical Care AG & Co. KGaA was founded in 1912.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.